Table 2.
Distribution of study participants by clinical manifestations and comorbidities (N=4141).
| Variables | Patients, n (%) | |
| Comorbidities | ||
|
|
No comorbidity | 2408 (48.2) |
|
|
Hypertension | 1021 (24.7) |
|
|
Diabetes mellitus | 939 (22.7) |
|
|
Heart diseases | 303 (7.3) |
|
|
Renal disease | 140 (3.4) |
|
|
Asthma | 111 (2.7) |
|
|
Respiratory diseases (COPDa and other respiratory diseases) | 61 (1.5) |
|
|
Malignancy | 62 (1.5) |
|
|
Immune compromising conditions | 45 (1.1) |
|
|
Liver disease | 22 (0.5) |
| Symptoms | ||
|
|
Asymptomatic | 124 (3.0) |
|
|
Fever | 3198 (77.2) |
|
|
Cough | 3009 (72.7) |
|
|
Shortness of breath | 2224 (53.7) |
|
|
Musculoskeletal manifestations | 1557 (37.6) |
|
|
Sore throat | 683 (16.5) |
|
|
Headache | 664 (16.0) |
|
|
Loss of taste or smell | 474 (11.4) |
|
|
Chest pain | 458 (11.1) |
|
|
Gastrointestinal or gastroenteric symptoms (nausea/vomiting/diarrhea/abdominal pain) | 364 (8.8) |
|
|
Sputum production | 156 (3.8) |
|
|
Nasal congestion | 118 (2.8) |
|
|
Conjunctival congestion | 37 (0.9) |
|
|
Hemoptysis | 36 (0.9) |
|
|
Other symptoms | 134 (3.2) |
aCOPD: chronic obstructive pulmonary disease.